Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Der Urologe. Ausg. A
|
October 21, 2010
[Signal transduction in urothelial cancer: how exactly do we know the targets for targeted therapy?]
G Niegisch, A Koch, J Knievel, et al.
Der Urologe. Ausg. A
|
April 4, 2020
[Report from the 9th symposium of the German Association for Bladder Cancer Research]
W A Schulz, M J Hoffmann, G Niegisch, et al.
Der Urologe. Ausg. A
|
December 1, 2021
[Imaging of oligometastatic disease in selected urologic cancers]
S A Koerber, C A Fink, K Dendl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 5, 2010
Randomized phase III trial of 2nd line gemcitabine and paclitaxel chemotherapy in patients with advanced bladder cancer: short-term versus prolonged treatment [German Association of Urological Oncology (AUO) trial AB 20/99]
P Albers, S-I Park, G Niegisch, et al.
Urologie (Heidelberg, Germany)
|
August 26, 2024
[German expert consensus on programmed cell death ligand 1 (PD-L1) testing in perioperative systemic therapy of muscle invasive bladder cancer]
G Niegisch, C Bolenz, C Doehn, et al.
Abdominal Radiology (New York)
|
October 31, 2023
MRI characteristics and oncological follow-up of patients with ISUP grade group 4 or 5 prostate cancer
M Boschheidgen, L Schimmöller, R Kastl, et al.
Molecular Imaging and Biology
|
November 12, 2022
PSMA-1007 Uptake in Ganglia of the Sympathetic Trunk and Its Intra-individual Reproducibility
E Mamlins, D Schmitt, M Beu, et al.
Molecular Imaging and Biology
|
March 29, 2022
Head-to-head Intra-individual Comparison of [<sup>68</sup>Ga]-FAPI and [<sup>18</sup>F]-FDG PET/CT in Patients with Bladder Cancer
E Novruzov, K Dendl, H Ndlovu, et al.
Clinical Genitourinary Cancer
|
June 6, 2016
Impact of Prior Platinum-Based Therapy on Patients Receiving Salvage Systemic Treatment for Advanced Urothelial Carcinoma
G Sonpavde, G R Pond, G Di Lorenzo, et al.
Clinical Genitourinary Cancer
|
July 5, 2014
Impact of the number of prior lines of therapy and prior perioperative chemotherapy in patients receiving salvage therapy for advanced urothelial carcinoma: implications for trial design
G R Pond, J Bellmunt, J E Rosenberg, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Der Urologe. Ausg. A
|
October 21, 2010
[Signal transduction in urothelial cancer: how exactly do we know the targets for targeted therapy?]
G Niegisch, A Koch, J Knievel, et al.
Der Urologe. Ausg. A
|
April 4, 2020
[Report from the 9th symposium of the German Association for Bladder Cancer Research]
W A Schulz, M J Hoffmann, G Niegisch, et al.
Der Urologe. Ausg. A
|
December 1, 2021
[Imaging of oligometastatic disease in selected urologic cancers]
S A Koerber, C A Fink, K Dendl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 5, 2010
Randomized phase III trial of 2nd line gemcitabine and paclitaxel chemotherapy in patients with advanced bladder cancer: short-term versus prolonged treatment [German Association of Urological Oncology (AUO) trial AB 20/99]
P Albers, S-I Park, G Niegisch, et al.
Urologie (Heidelberg, Germany)
|
August 26, 2024
[German expert consensus on programmed cell death ligand 1 (PD-L1) testing in perioperative systemic therapy of muscle invasive bladder cancer]
G Niegisch, C Bolenz, C Doehn, et al.
Abdominal Radiology (New York)
|
October 31, 2023
MRI characteristics and oncological follow-up of patients with ISUP grade group 4 or 5 prostate cancer
M Boschheidgen, L Schimmöller, R Kastl, et al.
Molecular Imaging and Biology
|
November 12, 2022
PSMA-1007 Uptake in Ganglia of the Sympathetic Trunk and Its Intra-individual Reproducibility
E Mamlins, D Schmitt, M Beu, et al.
Molecular Imaging and Biology
|
March 29, 2022
Head-to-head Intra-individual Comparison of [<sup>68</sup>Ga]-FAPI and [<sup>18</sup>F]-FDG PET/CT in Patients with Bladder Cancer
E Novruzov, K Dendl, H Ndlovu, et al.
Clinical Genitourinary Cancer
|
June 6, 2016
Impact of Prior Platinum-Based Therapy on Patients Receiving Salvage Systemic Treatment for Advanced Urothelial Carcinoma
G Sonpavde, G R Pond, G Di Lorenzo, et al.
Clinical Genitourinary Cancer
|
July 5, 2014
Impact of the number of prior lines of therapy and prior perioperative chemotherapy in patients receiving salvage therapy for advanced urothelial carcinoma: implications for trial design
G R Pond, J Bellmunt, J E Rosenberg, et al.
Page
of 3